Synapse - Genitourinary Oncology Service

Search Within

Genitourinary Oncology Service

Results (5692)

First-line everolimus followed by second-line sunitinib versus the opposite treatment sequence in patients with metastatic renal cell carcinoma (mRCC)+

Meeting Abstract

Knox, J. J.; Kay, A. C.; Schiff, E.; Hollaender, N.; Rouyrre, N.; Ravaud, A.; Motzer, R. J.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Overall survival (OS) of metastatic renal cell carcinoma (mRCC) patients corrected for crossover using inverse probability of censoring weights (IPCW) and rank preserving structural failure time (RPSFT) models: Two analyses from the RECORD-1 trial

Meeting Abstract

Korhonen, P.; Malangone, E.; Sherman, S.; Casciano, R.; Motzer, R. J.; Baladi, J.; Haas, T.; Zuber, E.; Kay, A. C.; Lebwohl, D. E.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Prostate cancer with disseminated intravascular coagulation and excessive fibrinolysis (DIC XFL)

Meeting Abstract

Hyman, D. M.; Scher, H. I.; Kampel, L. J.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Susceptibility loci associated with prostate cancer progression and mortality

Meeting Abstract

Gallagher, D. J.; Joseph, V.; Cronin, A.; Vickers, A. J.; Reuter, V. E.; Scher, H. I.; Eastham, J.; Lilja, H.; Kirchhoff, T.; Offit, K.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Sunitinib (SU)-related hypertension in a randomized placebo (P)-controlled trial of GIST patients (pts)

Meeting Abstract

Ewer, M.; Suter, T. M.; Lenihan, D. J.; Niculescu, L.; Breazna, A.; Motzer, R. J.; Demetri, G. D.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Progression-free survival (PFS) as a new endpoint for designing phase II trials in patients with refractory germ cell tumors (GCT)

Meeting Abstract

Feldman, D. R.; Patil, S.; Trinos, M. J.; Carousso, M.; Ginsberg, M. S.; Sheinfeld, J.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Phase I trial of pulse-dose vorinostat with flavopiridol in solid tumors

Meeting Abstract

Dickson, M. A.; Rathkopf, D. E.; Grant, S.; Roberts, J. D.; Reid, J. M.; Ames, M. M.; McGovern, R. M.; Gonen, M.; Dials, H. J.; Schwartz, G. K.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Molecular profiling of circulating tumor cells (CTC) in patients with castrate metastatic prostate cancer (CMPC) receiving abiraterone acetate (AA) after failure of docetaxel-based chemotherapy

Meeting Abstract

Danila, D. C.; Anand, A.; Sung, C. C.; Leversha, M.; Rathkopf, D. E.; Morris, M. J.; Slovin, S. F.; Molina, A.; Fleisher, M.; Scher, H. I.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Phase I pharmacokinetic (PK) and biodistribution study of radium-223 chloride in patients with castration resistant prostate cancer (CRPC) metastatic to bone

Meeting Abstract

Carrasquillo, J. A.; O'Donoghue, J. A.; Pandit-Taskar, N.; Rathkopf, D. E.; Aksnes, A.; Viner, C. L.; Hong, C. T.; Larson, S. M.; Scher, H. I.; Morris, M. J.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Antitumor activity of SNX-2112, a synthetic heat shock protein 90 inhibitor, in malignancies with amplification of the MET oncogene

Meeting Abstract

Bachleitner-Hofmann, T.; Sun, M. Y.; Chen, C.; Zeng, Z.; Viale, A.; Olshen, A.; Christensen, J. G.; Rosen, N.; Solit, D. B.; Weiser, M. R.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save